The molecular subtyping of breast cancer and its clinical treatment significance / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
; (12): 2309-2312, 2018.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-807835
Biblioteca responsável:
WPRO
ABSTRACT
The breast cancer is a usual and serious malignant tumor which threatens the women′s health.Molecular subtyping bases on the molecular level, and provides a new classification method for the breast cancer pathology classification, and plays an important guidance significance for the clinical treatment.At present, the breast cancer molecular subtyping is mainly divided into the following subtypes the Luminal A type and Luminal B type, HER-2 overexpression and the triple negative breast cancer.Different molecular subtyping has different characteristics in treatment reaction, prognosis and the clinical application situation.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Guia de prática clínica
/
Estudo prognóstico
Idioma:
Chinês
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Ano de publicação:
2018
Tipo de documento:
Artigo